On January 31, 2024 AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, reported that Daniel Faga, president and chief executive officer, will present at Guggenheim’s 6th Annual Biotechnology Conference (Press release, AnaptysBio, JAN 31, 2024, View Source [SID1234639739]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Conference Details

Event – Guggenheim’s 6th Annual Biotechnology Conference
Format – Fireside chat
Date and Time – Wednesday, Feb. 7, 2024 at 9:30am ET / 6:30am PT
A live webcast of the fireside chat will be available on the investor section of the Anaptys website at View Source A replay of the webcast will be available for at least 30 days following the event.